Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Recruiting Phase 1 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04486001Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19